If a patient takes a drug that is available in a non-oral formulation (e.g., transdermal estradiol instead of oral estradiol, patch-based hormone therapy instead of oral HRT), switching reduces the interaction risk without requiring drug-level monitoring
Below is a comparison of Dihexa with the most commonly considered alternatives
Metabolic Engineering addresses a broader range of inflammatory triggers that cause metabolic damage than do GLP-1 drugs
TMPRSS2 suppresses endogenous GLP-1mediated glucose homeostasis in DIO
Muscle mass is a powerful predictor of longevity, supports bone density, improves metabolic health, and helps stabilize blood sugar
NICE guidelines (NG28) recommend blood pressure targets below 140/80 mmHg (or 130/80 mmHg if kidney, eye, or cerebrovascular damage is present) and lipid management according to cardiovascular risk